Header Logo

Connection

FIDA BACHA to Humans

Back to Details
This is a "connection" page, showing publications FIDA BACHA has written about Humans.
FIDA BACHA
Connection Strength
0.869
Humans
  1. Prediction models of basal energy expenditure in children and adolescents across the BMI spectrum based on room calorimetry: a cross-sectional cohort study. Am J Clin Nutr. 2025 Feb; 121(2):284-292.
    View in: PubMed
    Score: 0.026
  2. Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
    View in: PubMed
    Score: 0.026
  3. Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
    View in: PubMed
    Score: 0.025
  4. Prognostic factors in resolution of nonalcoholic fatty liver disease post bariatric surgery in adolescents. Surg Obes Relat Dis. 2024 Apr; 20(4):367-375.
    View in: PubMed
    Score: 0.024
  5. Hyperglycemia: A determinant of cardiac autonomic dysfunction in youth with obesity across the spectrum of glycemic regulation. Pediatr Obes. 2023 10; 18(10):e13063.
    View in: PubMed
    Score: 0.024
  6. Candidate biomarkers as predictors of future kidney disease and cardiovascular dysfunction in adolescents with type 2 diabetes. Diabetes Res Clin Pract. 2023 May; 199:110671.
    View in: PubMed
    Score: 0.023
  7. The roles of sleep and eating patterns in adiposity gain among preschool-aged children. Am J Clin Nutr. 2022 11; 116(5):1334-1342.
    View in: PubMed
    Score: 0.023
  8. Adiposity, Insulin Resistance, Cardiorespiratory Fitness, and Bone Health in Hispanic Children. J Clin Endocrinol Metab. 2022 08 18; 107(9):e3797-e3804.
    View in: PubMed
    Score: 0.022
  9. Metabolic flexibility across the spectrum of glycemic regulation in youth. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.020
  10. The relationship of sleep duration and quality to energy expenditure and physical activity in children. Pediatr Obes. 2021 06; 16(6):e12751.
    View in: PubMed
    Score: 0.020
  11. GLP-1 Receptor Agonist as Adjuvant Therapy in Type 1 Diabetes: No Apparent Benefit for Beta-Cell Function or Glycemia. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.019
  12. Decline Pattern of Beta Cell Function in LADA: Relationship to GAD Autoantibodies. J Clin Endocrinol Metab. 2020 08 01; 105(8).
    View in: PubMed
    Score: 0.019
  13. Predictors of response to insulin therapy in youth with poorly-controlled type 2 diabetes in the TODAY trial. Pediatr Diabetes. 2019 11; 20(7):871-879.
    View in: PubMed
    Score: 0.018
  14. FDA approval of GLP-1 receptor agonist (liraglutide) for use in children. Lancet Child Adolesc Health. 2019 09; 3(9):595-597.
    View in: PubMed
    Score: 0.018
  15. Free Vitamin D: Relationship to Insulin Sensitivity and Vascular Health in Youth. J Pediatr. 2019 09; 212:28-34.e2.
    View in: PubMed
    Score: 0.018
  16. Initial Presentation of Type 2 Diabetes in Adolescents Predicts Durability of Successful Treatment with Metformin Monotherapy: Insights from the Pediatric Diabetes Consortium T2D Registry. Horm Res Paediatr. 2018; 89(1):47-55.
    View in: PubMed
    Score: 0.016
  17. Race or vitamin D: A determinant of intima media thickness in obese adolescents? Pediatr Diabetes. 2017 Nov; 18(7):619-621.
    View in: PubMed
    Score: 0.015
  18. Endothelial Function in Youth: A Biomarker Modulated by Adiposity-Related Insulin Resistance. J Pediatr. 2016 Nov; 178:171-177.
    View in: PubMed
    Score: 0.015
  19. Relationship of Cardiac Structure and Function to Cardiorespiratory Fitness and Lean Body Mass in Adolescents and Young Adults with Type 2 Diabetes. J Pediatr. 2016 10; 177:159-166.e1.
    View in: PubMed
    Score: 0.015
  20. Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes. Curr Diab Rep. 2016 07; 16(7):62.
    View in: PubMed
    Score: 0.015
  21. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes. Pediatr Diabetes. 2016 12; 17(8):545-558.
    View in: PubMed
    Score: 0.014
  22. Urine Albumin-to-Creatinine Ratio: A Marker of Early Endothelial Dysfunction in Youth. J Clin Endocrinol Metab. 2015 Sep; 100(9):3393-9.
    View in: PubMed
    Score: 0.014
  23. Mother's pre-pregnancy BMI is an important determinant of adverse cardiometabolic risk in childhood. Pediatr Diabetes. 2015 Sep; 16(6):419-26.
    View in: PubMed
    Score: 0.013
  24. Coronary artery calcification in obese youth: what are the phenotypic and metabolic determinants? Diabetes Care. 2014 Sep; 37(9):2632-9.
    View in: PubMed
    Score: 0.013
  25. Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood. Fertil Steril. 2013 Jul; 100(1):2-11.
    View in: PubMed
    Score: 0.012
  26. Indices of insulin secretion during a liquid mixed-meal test in obese youth with diabetes. J Pediatr. 2013 May; 162(5):924-9.
    View in: PubMed
    Score: 0.011
  27. Progressive deterioration of ?-cell function in?obese youth with type 2 diabetes. Pediatr Diabetes. 2013 Mar; 14(2):106-11.
    View in: PubMed
    Score: 0.011
  28. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012 Nov; 61(11):2787-95.
    View in: PubMed
    Score: 0.011
  29. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012 Aug; 13(5):376-83.
    View in: PubMed
    Score: 0.011
  30. Type 2 diabetes in youth: are there racial differences in ?-cell responsiveness relative to insulin sensitivity? Pediatr Diabetes. 2012 May; 13(3):259-65.
    View in: PubMed
    Score: 0.010
  31. From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation. Diabetes Care. 2010 Oct; 33(10):2225-31.
    View in: PubMed
    Score: 0.010
  32. The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D Exchange. Diabetes Care. 2020 04; 43(4):806-812.
    View in: PubMed
    Score: 0.009
  33. In vivo insulin sensitivity and secretion in obese youth: what are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes? Diabetes Care. 2009 Jan; 32(1):100-5.
    View in: PubMed
    Score: 0.009
  34. Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test. J Pediatr. 2008 May; 152(5):618-21.
    View in: PubMed
    Score: 0.008
  35. Are obesity-related metabolic risk factors modulated by the degree of insulin resistance in adolescents? Diabetes Care. 2006 Jul; 29(7):1599-604.
    View in: PubMed
    Score: 0.007
  36. Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab. 2006 Aug; 91(8):3117-22.
    View in: PubMed
    Score: 0.007
  37. Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience. Pediatr Obes. 2017 08; 12(4):337-345.
    View in: PubMed
    Score: 0.007
  38. HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes. Diabetes Care. 2015 Dec; 38(12):2285-92.
    View in: PubMed
    Score: 0.007
  39. Metabolic syndrome is common and persistent in youth-onset type 2 diabetes: Results from the TODAY clinical trial. Obesity (Silver Spring). 2015 Jul; 23(7):1357-61.
    View in: PubMed
    Score: 0.007
  40. Does adiponectin explain the lower insulin sensitivity and hyperinsulinemia of African-American children? Pediatr Diabetes. 2005 Jun; 6(2):100-2.
    View in: PubMed
    Score: 0.007
  41. Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab. 2005 May; 90(5):2725-30.
    View in: PubMed
    Score: 0.007
  42. Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
    View in: PubMed
    Score: 0.007
  43. Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty. J Clin Psychopharmacol. 2024 Nov-Dec; 44(6):538-544.
    View in: PubMed
    Score: 0.006
  44. The association of self-reported sleep and circadian measures with glycemic control and diabetes complications among young adults with type 2 diabetes. Am J Physiol Heart Circ Physiol. 2024 06 01; 326(6):H1386-H1395.
    View in: PubMed
    Score: 0.006
  45. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care. 2004 Feb; 27(2):547-52.
    View in: PubMed
    Score: 0.006
  46. Baseline leptin predicts response to metformin in adolescents with type 1 diabetes and increased body mass index. Diabetes Obes Metab. 2023 11; 25(11):3420-3423.
    View in: PubMed
    Score: 0.006
  47. Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab. 2003 Jun; 88(6):2534-40.
    View in: PubMed
    Score: 0.006
  48. Estimating circadian phase in elementary school children: leveraging advances in physiologically informed models of circadian entrainment and wearable devices. Sleep. 2022 06 13; 45(6).
    View in: PubMed
    Score: 0.006
  49. Relationship between Arterial Stiffness and Subsequent Cardiac Structure and Function in Young Adults with Youth-Onset Type 2 Diabetes: Results from the TODAY Study. J Am Soc Echocardiogr. 2022 06; 35(6):620-628.e4.
    View in: PubMed
    Score: 0.005
  50. Metabolic inflexibility in youth with obesity: Is it a feature of obesity or distinctive of youth who are metabolically unhealthy? Clin Obes. 2022 Apr; 12(2):e12501.
    View in: PubMed
    Score: 0.005
  51. Longitudinal changes in vascular stiffness and heart rate variability among young adults with youth-onset type 2 diabetes: results from the follow-up observational treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Acta Diabetol. 2022 Feb; 59(2):197-205.
    View in: PubMed
    Score: 0.005
  52. Type 2 diabetes in prepubertal children. Pediatr Diabetes. 2021 11; 22(7):946-950.
    View in: PubMed
    Score: 0.005
  53. Long-Term Complications in Youth-Onset Type 2 Diabetes. N Engl J Med. 2021 07 29; 385(5):416-426.
    View in: PubMed
    Score: 0.005
  54. TCF7L2 Genetic Variants Do Not Influence Insulin Sensitivity or Secretion Indices in Autoantibody-Positive Individuals at Risk for Type 1 Diabetes. Diabetes Care. 2021 09; 44(9):2039-2044.
    View in: PubMed
    Score: 0.005
  55. New syndrome characterized by sparse hair, prominent nose, small mouth, micrognathia, cleft palate, crumpled upper helices, digit anomaly, and mild developmental delay. Am J Med Genet. 2001 Jun 01; 101(1):70-3.
    View in: PubMed
    Score: 0.005
  56. Pasteurella multocida pneumonia in an adolescent with Duchenne's muscular dystrophy following exposure to his helper dog. Clin Pediatr (Phila). 2001 Mar; 40(3):159-61.
    View in: PubMed
    Score: 0.005
  57. Challenges and Opportunities for the Prevention and Treatment of Cardiovascular Disease Among Young Adults: Report From a National Heart, Lung, and Blood Institute Working Group. J Am Heart Assoc. 2020 10 20; 9(19):e016115.
    View in: PubMed
    Score: 0.005
  58. ?-cell impairment and clinically meaningful alterations in glycemia in obese youth across the glucose tolerance spectrum. Metabolism. 2020 11; 112:154346.
    View in: PubMed
    Score: 0.005
  59. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study. Pediatr Diabetes. 2020 09; 21(6):923-931.
    View in: PubMed
    Score: 0.005
  60. Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry. J Clin Endocrinol Metab. 2020 05 01; 105(5).
    View in: PubMed
    Score: 0.005
  61. ?-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak. Pediatr Diabetes. 2020 02; 21(1):18-27.
    View in: PubMed
    Score: 0.005
  62. Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care. 2019 11; 42(11):2143-2150.
    View in: PubMed
    Score: 0.005
  63. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test: Forerunner of Heightened Glycemic Failure Rates and Accelerated Decline in ?-Cell Function in TODAY. Diabetes Care. 2019 01; 42(1):164-172.
    View in: PubMed
    Score: 0.004
  64. Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
    View in: PubMed
    Score: 0.004
  65. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatr Diabetes. 2018 12; 19(8):1379-1384.
    View in: PubMed
    Score: 0.004
  66. Response to Comment on Redondo et al. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018;41:1017-1024. Diabetes Care. 2018 07; 41(7):e125-e126.
    View in: PubMed
    Score: 0.004
  67. Prevalence of arterial stiffness in adolescents with type 2 diabetes in the TODAY cohort: Relationships to glycemic control and other risk factors. J Diabetes Complications. 2018 Aug; 32(8):740-745.
    View in: PubMed
    Score: 0.004
  68. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care. 2018 05; 41(5):1017-1024.
    View in: PubMed
    Score: 0.004
  69. Lipid Profiles, Inflammatory Markers, and Insulin Therapy in Youth with Type 2 Diabetes. J Pediatr. 2018 05; 196:208-216.e2.
    View in: PubMed
    Score: 0.004
  70. Diagnostic Evaluation, Comorbidity Screening, and Treatment of Polycystic Ovary Syndrome in Adolescents in 3 Specialty Clinics. J Pediatr Adolesc Gynecol. 2018 Aug; 31(4):367-371.
    View in: PubMed
    Score: 0.004
  71. Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr. 2018 01; 192:86-92.e5.
    View in: PubMed
    Score: 0.004
  72. Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical?Trial. Am J Kidney Dis. 2018 01; 71(1):65-74.
    View in: PubMed
    Score: 0.004
  73. Increased Lipolysis, Diminished Adipose Tissue Insulin Sensitivity, and Impaired ?-Cell Function Relative to Adipose Tissue Insulin Sensitivity in Obese Youth With Impaired Glucose Tolerance. Diabetes. 2017 12; 66(12):3085-3090.
    View in: PubMed
    Score: 0.004
  74. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: Who is worse off? Pediatr Diabetes. 2018 03; 19(2):205-211.
    View in: PubMed
    Score: 0.004
  75. Adiponectin, Insulin Sensitivity, ?-Cell Function, and Racial/Ethnic Disparity in Treatment Failure Rates in TODAY. Diabetes Care. 2017 Jan; 40(1):85-93.
    View in: PubMed
    Score: 0.004
  76. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth. Diabetes Care. 2016 Aug; 39(8):1431-9.
    View in: PubMed
    Score: 0.004
  77. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry. Pediatr Diabetes. 2017 05; 18(3):222-229.
    View in: PubMed
    Score: 0.004
  78. Differences in ?-cell function and insulin secretion in Black vs. White obese adolescents: do incretin hormones play a role? Pediatr Diabetes. 2017 03; 18(2):143-151.
    View in: PubMed
    Score: 0.004
  79. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2015 Dec 01; 314(21):2241-50.
    View in: PubMed
    Score: 0.004
  80. Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study Experience. Diabetes Care. 2016 Jan; 39(1):122-9.
    View in: PubMed
    Score: 0.004
  81. Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes. Pediatr Diabetes. 2016 12; 17(8):584-591.
    View in: PubMed
    Score: 0.004
  82. Depressive Symptoms in Youth With Type 1 or Type 2 Diabetes: Results of the Pediatric Diabetes Consortium Screening Assessment of Depression in Diabetes Study. Diabetes Care. 2015 Dec; 38(12):2341-3.
    View in: PubMed
    Score: 0.003
  83. Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp. Pediatr Diabetes. 2016 09; 17(6):458-65.
    View in: PubMed
    Score: 0.003
  84. Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States. J Pediatr. 2015 Sep; 167(3):627-32.e1-4.
    View in: PubMed
    Score: 0.003
  85. Pre-diabetes in overweight youth and early atherogenic risk. Metabolism. 2014 Dec; 63(12):1528-35.
    View in: PubMed
    Score: 0.003
  86. ?-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes. 2014 Nov; 63(11):3846-55.
    View in: PubMed
    Score: 0.003
  87. Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial. Pediatr Diabetes. 2015 Feb; 16(1):39-47.
    View in: PubMed
    Score: 0.003
  88. 25-Hydroxyvitamin D in obese youth across the spectrum of glucose tolerance from normal to prediabetes to type 2 diabetes. Diabetes Care. 2013 Jul; 36(7):2048-53.
    View in: PubMed
    Score: 0.003
  89. Measuring ?-cell function relative to insulin sensitivity in youth: does the hyperglycemic clamp suffice? Diabetes Care. 2013 Jun; 36(6):1607-12.
    View in: PubMed
    Score: 0.003
  90. Metabolomic profiling of amino acids and ?-cell function relative to insulin sensitivity in youth. J Clin Endocrinol Metab. 2012 Nov; 97(11):E2119-24.
    View in: PubMed
    Score: 0.003
  91. HbA(1c) diagnostic categories and ?-cell function relative to insulin sensitivity in overweight/obese adolescents. Diabetes Care. 2012 Dec; 35(12):2559-63.
    View in: PubMed
    Score: 0.003
  92. Oral disposition index in obese youth from normal to prediabetes to diabetes: relationship to clamp disposition index. J Pediatr. 2012 Jul; 161(1):51-7.
    View in: PubMed
    Score: 0.003
  93. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation. Diabetes Care. 2012 Mar; 35(3):605-11.
    View in: PubMed
    Score: 0.003
  94. Cross-sectional association between blood pressure, in vivo insulin sensitivity and adiponectin in overweight adolescents. Horm Res Paediatr. 2011; 76(6):379-85.
    View in: PubMed
    Score: 0.003
  95. Declining ?-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth. Diabetes Care. 2011 Sep; 34(9):2033-40.
    View in: PubMed
    Score: 0.003
  96. Surrogate estimates of insulin sensitivity in obese youth along the spectrum of glucose tolerance from normal to prediabetes to diabetes. J Clin Endocrinol Metab. 2011 Jul; 96(7):2136-45.
    View in: PubMed
    Score: 0.003
  97. One-hour plasma glucose concentration during the OGTT: what does it tell about ?-cell function relative to insulin sensitivity in overweight/obese children? Pediatr Diabetes. 2011 Sep; 12(6):572-9.
    View in: PubMed
    Score: 0.003
  98. ?-cell autoimmunity in overweight non-diabetic youth: any implications? Pediatr Diabetes. 2011 May; 12(3 Pt 2):207-11.
    View in: PubMed
    Score: 0.002
  99. Islet cell antibody-positive versus -negative phenotypic type 2 diabetes in youth: does the oral glucose tolerance test distinguish between the two? Diabetes Care. 2010 Mar; 33(3):632-8.
    View in: PubMed
    Score: 0.002
  100. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes. 2009 Mar; 58(3):738-44.
    View in: PubMed
    Score: 0.002
  101. Hyperinsulinemia in African-American adolescents compared with their American white peers despite similar insulin sensitivity: a reflection of upregulated beta-cell function? Diabetes Care. 2008 Jul; 31(7):1445-7.
    View in: PubMed
    Score: 0.002
  102. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr. 2008 Feb; 152(2):177-84.
    View in: PubMed
    Score: 0.002
  103. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. 2007 Aug; 30(8):2091-7.
    View in: PubMed
    Score: 0.002
  104. Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr. 2006 Dec; 149(6):809-16.
    View in: PubMed
    Score: 0.002
  105. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes. 2006 Oct; 7(5):260-6.
    View in: PubMed
    Score: 0.002
  106. Cardiorespiratory fitness in youth: relationship to insulin sensitivity and beta-cell function. Obesity (Silver Spring). 2006 Sep; 14(9):1579-85.
    View in: PubMed
    Score: 0.002
  107. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006 Feb; 148(2):188-94.
    View in: PubMed
    Score: 0.002
  108. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006 Jan; 29(1):51-6.
    View in: PubMed
    Score: 0.002
  109. Type 2 diabetes mellitus in youth: the complete picture to date. Pediatr Clin North Am. 2005 Dec; 52(6):1579-609.
    View in: PubMed
    Score: 0.002
  110. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. 2005 Mar; 28(3):638-44.
    View in: PubMed
    Score: 0.002
  111. Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth. Diabetes Care. 2005 Jan; 28(1):115-9.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.